Impact of age on indication for chemotherapy in early breast cancer patients: results from 104 German institutions from 2008 to 2017

PURPOSE: Today, the decision to treat patients with chemotherapy for early breast cancer (EBC) is made based on the patient’s individual risk stratification and tumor biology. In cases with chemotherapy indication, the neoadjuvant application (NACT) is the preferred option in comparison with primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Ann Sophie, Hennigs, André, Feisst, Manuel, Moderow, Mareike, Heublein, Sabine, Deutsch, Thomas Maximilian, Togawa, Riku, Schäfgen, Benedikt, Wallwiener, Markus, Golatta, Michael, Heil, Jörg, Riedel, Fabian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191903/
https://www.ncbi.nlm.nih.gov/pubmed/36604331
http://dx.doi.org/10.1007/s00404-022-06902-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191903/
https://www.ncbi.nlm.nih.gov/pubmed/36604331
http://dx.doi.org/10.1007/s00404-022-06902-9

Ejemplares similares